[New drugs. 9].
D000726:Androgen Antagonists; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003534:Cyproterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004696:Endocarditis / Q000188:drug therapy; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D010262:Paraphilic Disorders / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011245:Pregnadienes / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013752:Tetracycline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy; D014820:Vitiligo / Q000188:drug therapy
D000726:Androgen Antagonists; D000903:Antibiotics, Antineoplastic; D003374:Coumarins; D011245:Pregnadienes; D001761:Bleomycin; D003534:Cyproterone; D013752:Tetracycline
Neue Arzneistoffe. 9.